A Phase 1, Fixed Sequence, Cross-Over Study To Investigate The Single Dose Pharmacokinetics Of A Dimebon (Latrepirdine) Transdermal Solution Relative To The Immediate Release Formulation In Older Adults.
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2010
At a glance
- Drugs Latrepirdine; Latrepirdine
- Indications Alzheimer's disease; Huntington's disease
- Focus Pharmacokinetics
- Sponsors Pfizer
- 02 Feb 2010 Actual patient number (19) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.